Literature DB >> 15687153

Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy.

Ginger E Holt1, Anthony M Griffin, Melania Pintilie, Jay S Wunder, Charles Catton, Brian O'Sullivan, Robert S Bell.   

Abstract

BACKGROUND: The purpose of the present retrospective study was to determine the correlation between radiation therapy and the risk of postradiation fracture following combined therapy for the treatment of soft-tissue sarcomas of the lower extremity.
METHODS: Three hundred and sixty-four patients with lower extremity sarcomas that had been treated with combined external beam radiation therapy and limb-salvage surgery were evaluated on the basis of a combined chart and data-base review. For the purposes of analysis, high-dose radiation was defined as 60 or 66 Gy and low-dose radiation was defined as 50 Gy. The timing of irradiation was defined as preoperative, postoperative, or preoperative followed by a postoperative boost. Univariate and multivariate analyses were used to determine which factors were associated with fracture risk.
RESULTS: Twenty-seven fractures occurred in twenty-three patients. Twenty-four fractures occurred in twenty patients who had been managed with high-dose radiation. Seventeen of these patients had received postoperative radiation (with fifteen patients receiving 66 Gy and two receiving 60 Gy), and three had received preoperative radiation with a postoperative boost (total dose, 66 Gy). Three fractures occurred in three patients who had received preoperative, low-dose radiation (50 Gy). Of the twenty-three patients who sustained a pathologic fracture, eighteen were female and five were male. The crude median time to fracture was forty-three months. Most fractures occurred in the femoral shaft (thirteen) or the femoral neck (eight). High-dose radiation was associated with a greater risk of fracture when compared with low-dose radiation (p = 0.007).
CONCLUSIONS: Women more than fifty-five years of age who are managed with removal of a thigh sarcoma combined with radiation therapy have a higher risk of pathologic fracture. The frequency of pathologic fractures associated with higher doses (60 or 66 Gy) of radiation is significantly higher than that associated with lower doses (50 Gy).

Entities:  

Mesh:

Year:  2005        PMID: 15687153     DOI: 10.2106/JBJS.C.01714

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  36 in total

Review 1.  Management of infection following reconstruction in bone tumors.

Authors:  Sudhir K Kapoor; Rajesh Thiyam
Journal:  J Clin Orthop Trauma       Date:  2015-07-07

2.  Deferoxamine reverses radiation induced hypovascularity during bone regeneration and repair in the murine mandible.

Authors:  Aaron S Farberg; Xi L Jing; Laura A Monson; Alexis Donneys; Catherine N Tchanque-Fossuo; Sagar S Deshpande; Steven R Buchman
Journal:  Bone       Date:  2012-02-01       Impact factor: 4.398

3.  Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms.

Authors:  Abhishek Chandra; Tiao Lin; Tiffany Young; Wei Tong; Xiaoyuan Ma; Wei-Ju Tseng; Ina Kramer; Michaela Kneissel; Michael A Levine; Yejia Zhang; Keith Cengel; X Sherry Liu; Ling Qin
Journal:  J Bone Miner Res       Date:  2016-10-20       Impact factor: 6.741

Review 4.  Extremity Soft Tissue Sarcoma: Role of Local Control.

Authors:  Elyse J Brinkmann; Safia K Ahmed; Matthew T Houdek
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

Review 5.  Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors.

Authors:  Danielle E Green; Clinton T Rubin
Journal:  Bone       Date:  2014-03-05       Impact factor: 4.398

6.  Long-term loss of osteoclasts and unopposed cortical mineral apposition following limited field irradiation.

Authors:  Megan E Oest; Veerle Franken; Timothy Kuchera; Judy Strauss; Timothy A Damron
Journal:  J Orthop Res       Date:  2014-11-18       Impact factor: 3.494

7.  Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.

Authors:  Abhishek Chandra; Luqiang Wang; Tiffany Young; Leilei Zhong; Wei-Ju Tseng; Michael A Levine; Keith Cengel; X Sherry Liu; Yejia Zhang; Robert J Pignolo; Ling Qin
Journal:  FASEB J       Date:  2017-08-31       Impact factor: 5.191

8.  Femoral Fracture in Primary Soft-Tissue Sarcoma of the Thigh and Groin Treated with Intensity-Modulated Radiation Therapy: Observed versus Expected Risk.

Authors:  Michael R Folkert; Dana L Casey; Sean L Berry; Aimee Crago; Nicola Fabbri; Samuel Singer; Kaled M Alektiar
Journal:  Ann Surg Oncol       Date:  2019-01-31       Impact factor: 5.344

Review 9.  Imaging applications in multicatheter brachytherapy for soft tissue sarcomas.

Authors:  Jennifer L Harper; John M Watkins; Michael Ashenafi; Jun Li
Journal:  Cancer Imaging       Date:  2010-06-17       Impact factor: 3.909

10.  A 57-year-old man with a history of prostatectomy and pelvic irradiation presents with recurrent urinary tract infections, hematuria, and pelvic pain.

Authors:  David C Moore; Kirk A Keegan; Matthew J Resnick; Rosana Eisenberg; Ginger E Holt; Michael S Cookson
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.